
CeNeRx BioPharma
CeNeRx.com - Medicines For The Mind.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | $5.2m | Debt | |
Total Funding | 000k |
Related Content
Cenerx operates in the biopharmaceutical sector, focusing on the analysis of weight loss supplements and dietary research. The company targets individuals seeking alternative solutions to traditional weight loss methods, such as herbal medicines and supplements. Cenerx's business model revolves around researching and analyzing the effects of various extracts and food ingredients, with a current emphasis on coleus forskohlii root extract, commonly known as forskolin. This natural compound is claimed to aid in safe and steady weight loss, appealing to a market of health-conscious consumers. Revenue is likely generated through partnerships with supplement manufacturers and sales of research findings. The company positions itself as a specialist in understanding the clinical science behind weight loss supplements, providing valuable insights to both consumers and industry stakeholders.
Keywords: biopharmaceutical, weight loss, supplements, dietary research, forskolin, coleus forskohlii, herbal medicine, health, analysis, extracts.